The future of medicine: How innovations will catalyse quantum leaps in healthcare by 2055
What was once considered science fiction — remote diagnostics, AI in surgery, 3D-printed organs — has become medical reality. The next 30 years will redefine what it means to be treated, cured and cared for
"It is the essence of science to change the way we think about the world around us and ourselves" — this statement by science journalist Barbara J Culliton has probably had the most profound impact on the medicine industry, impacting the way medicine is being reimagined and redefined.
For example, around 10 years ago, it was predicted that patients would have access to medicine specifically tailored to their needs, and significant advancements in genetic engineering would be achieved.
Fast forward to 2025, scientists and medical professionals have achieved significant advancements in genetic engineering, particularly with the development of CRISPR-Cas9 and other gene editing tools, which are contributing significantly to advancing research initiatives and enabling modifications of DNA sequences.
Moreover, telemedicine, considered a pipedream even 10 or 15 years ago, has become the new trend in the healthcare sector.
Keep updated, follow The Business Standard's Google news channel
Telemedicine is gaining momentum at an unprecedented rate, with more than 116 million people using digital health treatment globally in 2024, which was just 57 million in 2019. The telemedicine market is forecasted to reach $121 billion in 2025 and $432.31 billion by 2032.
There is no denying that more than what was predicted 10 years ago has been achieved in the medical industry, and experts believe that this is just the beginning of something more transformative and phenomenal.
With the meteoric advancement of science and technology, it is very intuitive that the field of medicine will undergo seismic changes, translating innovations into clinical applications and improving lives. So, fast forward to 30 or 50 years, what would medicine look like in 2055?
The technologies that will have the biggest impact are those that allow the patient to become the point of care — not just in their homes, but wherever they are.
Most experts are of the opinion that there will be quantum leaps in the field of medicine in the next 50 years, opening up new windows of possibilities defined by personalised and precision medicine, AI-driven healthcare and technological advancements like nanotechnology.
The biggest change will be observed in the approach. Dr Bertalan Meskó, Director of the Medical Futurist Institute, told the BBC, "The technologies that will have the biggest impact are those that allow the patient to become the point of care — not just in their homes, but wherever they are."
It means that there will be a time in the future when the patients will not have to make frequent visits to the hospital or diagnostic centres to get complex diagnostic procedures done; rather, those tests could be conducted by patients themselves with the help of modern AI-supported technologies.
Artificial intelligence (AI) and machine learning (ML) will be transforming medical diagnostics, drug development, and public health monitoring. AI algorithms can quickly and accurately process huge datasets, spotting trends that guide both personalised treatment and broader health initiatives.
In radiology, AI-based solutions will be aiding in the early and precise detection of complex diseases such as lung cancer.
According to Fortune Business Insights, the global AI in healthcare market size is projected to grow from $39.25 billion in 2025 to $504.17 billion by 2032. The growth rate is expected to grow at a faster rate in the next few decades as modern technologies like AI will have a drastic impact on medicine and the healthcare sector.
Apart from this, after half a century, there is a strong possibility that effective treatments and even cures for diseases such as HIV, hepatitis C, and cancer will be developed by researchers. For example, in a recent breakthrough, researchers from the Peter Doherty Institute for Infection and Immunity in Melbourne have demonstrated for the first time that mRNA can be delivered into the cells where HIV is hiding, which will help to make the virus visible, paving the way to fully clear the virus from the infected body.
At the moment, there are around 40 million people in the world living with HIV. Almost one person died of HIV every minute in 2023. While it may sound like an overstatement now, it is very much possible that healthcare professionals could come up with an effective treatment following in the footsteps of the Melbourne researchers within the next 15 or 20 years.
Another global concern is the ageing issue. According to UN estimates, the number of people aged 65 years or over is predicted to double between 2020 and 2050, reaching 1.5 billion from 703 million. More aged people mean more complications and comorbidities.
It is possible to treat diseases related to aging, such as diabetes, arthritis, optic nerve stroke, glaucoma, dementia and others through cellular reprogramming, and the good news is that researchers are into it.
Human experiments using cellular reprogramming are not a distant dream anymore, and in the future (maybe in 2055), researchers are expected to make great leaps in this kind of programming that will help treat more complex ageing-related diseases.
With such breakthroughs in the offing, the definition of healthcare will change, making a shift from a reactive approach to one that is proactive, customised and preventive. Innovations combining genomics, transcriptomics, proteomics, and metabolomics under one umbrella will facilitate more precise predictions of individual disease susceptibility, enabling early intervention, even before any signs or symptoms appear.
By 2055, the traditional one-size-fits-all approach in medicine might become obsolete, making way for a more specific treatment process based on a person's genetic makeup, microbiome and real-time health information.
Even in the next few years, the global medicine market will keep growing at an exponential rate, pointing to greater advancements in the next few decades. Currently standing at $1.67 trillion (2024), the global pharmaceutical market size is predicted to increase from $1.77 trillion in 2025 to approximately $3.03 trillion by 2034.
Moreover, the telehealth sector is expected to reach nearly $791 billion by 2032 (MedTech World), whereas the 3D bioprinting market could reach $4.5 billion by 2033. The nanomedicine market is expected to exceed $500 billion within the next decade, whereas the regenerative medicine market will stand at $413 billion by 2032 (StartUs Insights).
According to Pulse, the leading publication for general practitioners in the UK, the following trends will define the field of medicine fast forward to 2055 or half a century: wearable and implanted technology will become the norm; artificial intelligence will analyse test results; patients will have full electronic access to all their health records; teleconsultations will be the first port of call; GPs will carry around portable miniature laboratories; diagnosis will be done by computer; genomic treatment will revolutionise patient care; drug dosing will be fully automated, and finally, stem-cell research, genetic engineering and 3D printing will allow patients to have bespoke replacement tissue and organs made.
It can be said, without a shadow of a doubt, that the future of medicine is poised to be very promising, with personalised therapies, AI-powered diagnostics, and biotechnology available within everyone's reach, catalysing a paradigm shift in public healthcare. What we are seeing in today's science fiction movies will be a reality just half a century later.
